Title |
Dermatomiosite juvenil: revisão e atualização em patogênese e tratamento
|
---|---|
Published in |
Advances in Rheumatology, June 2010
|
DOI | 10.1590/s0482-50042010000300010 |
Pubmed ID | |
Authors |
Nilton Salles Rosa Neto, Cláudia Goldenstein-Schainberg |
Abstract |
Juvenile dermatomyositis (JDM) is an autoimmune disease characterized by systemic vasculopathy. Its main manifestations include symmetrical proximal muscle weakness, elevated serum muscle enzymes and cutaneous lesions, among which the heliotrope and Gottron's papules are pathognomonic. Early recognition and prompt therapy allow better prognosis and prevent the development of calcinosis. Although the treatment is based on glucocorticoids, the more commonly associated immunosuppressors include methotrexate, azathioprine, cyclosporine, and cyclophosphamide, depending on the severity of disease. The use of immunobiologicals for refractory cases remains under investigation, but the results are controversial or inexpressive. In this review, we highlight recent updates on the pathogenesis and treatment of JDM. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 14 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 9 | 64% |
Student > Master | 3 | 21% |
Student > Postgraduate | 1 | 7% |
Unknown | 1 | 7% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 57% |
Nursing and Health Professions | 3 | 21% |
Agricultural and Biological Sciences | 1 | 7% |
Arts and Humanities | 1 | 7% |
Unknown | 1 | 7% |